Spasticity Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Dec 2023 Pages: 173 SKU: IRTNTR72357

Spasticity Treatment Market 2024-2028

The Global Spasticity Treatment Market size is estimated to grow by USD 1.61 billion at a CAGR of 5.5% between 2023 and 2028. 

There has been an increasing availability of advanced technologies for drug delivery over the years. The global spasticity treatment market has numerous combination therapy options that provide high efficacy, which will increase the patient base, thereby fuelling market growth. For instance, as per the article published in the National Center for Biotechnology Information. (NCBI), the administration of intrathecal ziconotide and baclofen has been found to provide pain relief in patients with neuropathic pain and spasticity. Hence, such combination therapies have the potential to attract the attention of more medical practitioners and thus, positively impact the market growth.

Technavio has segmented the market into Type, End-user, and Geography

  • The type segment is classified into drug therapy, physical therapy, and surgical treatment
  • The end-user segment is classified into hospitals, ambulatory surgical centers, home care settings, specialty clinics, and diagnostic centers
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Spasticity Treatment Market During the Forecast Period?

To learn more about this report, Download Report Sample

Spasticity Treatment Market Segmentation by Type, End-user, and Geography Analysis

Type Analysis

Drug therapy

The drug therapy segment is estimated to witness significant growth during the forecast period. The main factor fuelling the growth of the drug therapy segment is the growing cases of associated risk factors globally. In addition, the imbalance in signals from the CNS to the muscles is often found in people with chronic conditions such as cerebral palsy, traumatic brain injury, spinal cord injury, stroke, and multiple sclerosis.

Get a glance at the market contribution of various segments Download PDF Sample

The drug therapy segment was the largest segment and was valued at USD 2.90 billion in 2018. Moreover, the growing adoption of stressful and technologically advanced lifestyles is spurring the incidence of these diseases across the globe. For instance, as per the Centers for Disease Control and Prevention (CDC), every year, more than 795,000 people in the US have a stroke. In addition, about half of the people who survive after having a stroke suffer from muscle spasticity. Furthermore, as drug therapy is easily accessible to most patients, it naturally becomes the first choice of treatment, which, thus, makes it the segment with the larger share in the global spasticity treatment market. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis

Hospitals

Hospitals segment serve as crucial service providers for spasticity treatment, offering comprehensive care and specialized interventions for individuals affected by spasticity-related conditions. In addition, these facilities offer a variety of services that are necessary for the diagnosis, treatment, and recovery of patients suffering from spasticity. Moreover, hospitals provide a range of treatment options such as prescription drugs, physical therapy, injections of botulinum toxin, orthotic devices, and surgical procedures, including intrathecal baclofen pump implantation or selective dorsal rhizotomy. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Ambulatory surgical centers

Ambulatory surgical centers (ASCs) provide specialized services for spasticity treatment, providing a more focused and efficient environment for certain procedures and interventions. In addition, these centers cater to patients requiring outpatient surgical care for spasticity-related conditions. Moreover, ASCs are outfitted with the most advanced infrastructure and technology required to carry out treatments for spasticity, including injections of botulinum toxin, surgeries to release tendons, or procedures involving specific nerves. Furthermore, these facilities prioritize giving patients comfortable, high-quality care while maintaining patient safety. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market growth in North America is due to the high-risk factors for spasticity in the region. In addition, the increasing prevalence of multiple sclerosis propels the incidence of spasticity in this region, as spasticity is a symptom of multiple sclerosis. Moreover, healthcare reforms in the US are having a positive impact on the growth of the market. Furthermore, the implementation of the Affordable Care Act is rapidly changing the business environment of the pharmaceutical industry in the US. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Spasticity Treatment Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories: The company offers spasticity treatments such as Proclaim DRG Neurostimulation System, and Infinity Deep Brain Stimulation system.

  • Axonics Inc.
  • BioWave Ltd.
  • Boston Scientific Corp.
  • BrainsWay Ltd.
  • electroCore Inc.
  • LivaNova Plc
  • Mayo Clinic
  • Medtronic Plc
  • NEURONETICS Inc.
  • Nevro Corp.
  • OMRON Corp.
  • PathMaker Neurosystems Inc.
  • Rady Childrens Hospital San Diego
  • Saebo Inc
  • Saluda Medical Pty Ltd.
  • ShiraTronics
  • The Johns Hopkins Health System Corp.
  • Theranica Bio Electronics Ltd.
  • Thync Global Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Spasticity Treatment Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Spasticity Treatment Market Drivers

One of the key factors driving the spasticity treatment market growth is the growing incidence of chronic diseases and health conditions. Spasticity is mainly caused by various chronic conditions that include damage to the portion of the brain or spinal cord that controls voluntary movement. In addition, primarily, spasticity occurs in patients who have CNS-related disorders such as multiple sclerosis and cerebral palsy, which affect the upper motor neurons in the form of lesions.

Moreover, the prevalence of these chronic neuro-musculoskeletal disorders is increasing worldwide, which, in turn, is increasing the incidence of spasticity. For instance, as per the Multiple Sclerosis Trust, about 2.5 million people around the world suffer from multiple sclerosis. Furthermore, the high prevalence of these conditions globally is because of the increase in the number of falls, road accidents, assaults, and other causes. Hence, such factors are driving the market growth during the forecast period.

Significant Spasticity Treatment Market Trends

A key factor shaping the spasticity treatment market growth is the advent of neurostimulation devices for spasticity treatment. The rise in the number of cases of chronic conditions is driving the prevalence of spasticity globally. In addition, this increasing prevalence of spasticity is motivating market players to not limit the treatment only to drug and physical therapy but to go beyond these therapies. Furthermore, the management of spasticity sometimes poses an unresolvable challenge due to the unmet need in the market.

Moreover, drug and physical treatments for the management of spasticity only offer short-term efficacy. In addition, these therapies are sometimes compounded by adverse side effects, which are often unpleasant for the patient. Therefore, to overcome this situation, many vendors in the market are developing devices, specifically neurostimulation devices, to treat spasticity in combination with the medications available.  Hence, such factors are driving the market growth during the forecast period.

Major Spasticity Treatment Market Challenges

Less insurance coverage and medical reimbursement are one of the key challenges hindering the spasticity treatment market growth. The unfavorable reimbursement policies for healthcare expenditure, especially related to physical therapies pose a major hurdle for the growth of the healthcare sector worldwide. In addition,  reimbursement policies affect the total healthcare expenditure, including that borne by the patient. 

Moreover, the other factor affecting the market in developing countries is the marginal presence of companies, corporations, and private organizations that provide medical reimbursements, which has a negative impact on the number of patients. In addition, a reduction in the patient pool leads to a decline in the number of patients opting for spasticity treatments, which limits the growth of the global spasticity treatment market during the forecast period.

Buy Now Full Report

Key Spasticity Treatment Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Spasticity Treatment Market Customer Landscape

Segment Overview

The spasticity treatment market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Drug therapy
    • Physical therapy
    • Surgical treatment
  • End-user Outlook
    • Hospitals
    • Ambulatory surgical centers
    • Home care settings
    • Specialty clinics
    • Diagnostic centers
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Spasticity Treatment Market Scope

Report Coverage

Details

Page number

173

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.5%

Market Growth 2024-2028

USD 1.61 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

4.6

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova Plc, Mayo Clinic, Medtronic Plc, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Childrens Hospital San Diego, Saebo Inc, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Spasticity Treatment Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the  spasticity treatment market between 2024 and 2028
  • Precise estimation of the spasticity treatment market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of spasticity treatment market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global spasticity treatment market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global spasticity treatment market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Drug therapy - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Drug therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
    • 6.4 Physical therapy - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Physical therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Physical therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Physical therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Physical therapy - Year-over-year growth 2023-2028 (%)
    • 6.5 Surgical treatment - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 50: Chart on Comparison by End-user
      • Exhibit 51: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Ambulatory surgical centers - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
    • 7.5 Home care settings - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Home care settings - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Home care settings - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
    • 7.6 Specialty clinics - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
    • 7.7 Diagnostic centers - Market size and forecast 2023-2028
      • Exhibit 68: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 70: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
      • Exhibit 71: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by End-user
      • Exhibit 72: Market opportunity by End-user ($ billion)
      • Exhibit 73: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 Canada - Market size and forecast 2023-2028
      • Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.11 Germany - Market size and forecast 2023-2028
      • Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ billion)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 Axonics Inc.
              • Exhibit 128: Axonics Inc. - Overview
              • Exhibit 129: Axonics Inc. - Business segments
              • Exhibit 130: Axonics Inc. - Key offerings
              • Exhibit 131: Axonics Inc. - Segment focus
            • 12.5 Boston Scientific Corp.
              • Exhibit 132: Boston Scientific Corp. - Overview
              • Exhibit 133: Boston Scientific Corp. - Business segments
              • Exhibit 134: Boston Scientific Corp. - Key news
              • Exhibit 135: Boston Scientific Corp. - Key offerings
              • Exhibit 136: Boston Scientific Corp. - Segment focus
            • 12.6 BrainsWay Ltd.
              • Exhibit 137: BrainsWay Ltd. - Overview
              • Exhibit 138: BrainsWay Ltd. - Product / Service
              • Exhibit 139: BrainsWay Ltd. - Key offerings
            • 12.7 electroCore Inc.
              • Exhibit 140: electroCore Inc. - Overview
              • Exhibit 141: electroCore Inc. - Product / Service
              • Exhibit 142: electroCore Inc. - Key offerings
            • 12.8 LivaNova Plc
              • Exhibit 143: LivaNova Plc - Overview
              • Exhibit 144: LivaNova Plc - Business segments
              • Exhibit 145: LivaNova Plc - Key offerings
              • Exhibit 146: LivaNova Plc - Segment focus
            • 12.9 Medtronic Plc
              • Exhibit 147: Medtronic Plc - Overview
              • Exhibit 148: Medtronic Plc - Business segments
              • Exhibit 149: Medtronic Plc - Key news
              • Exhibit 150: Medtronic Plc - Key offerings
              • Exhibit 151: Medtronic Plc - Segment focus
            • 12.10 NEURONETICS Inc.
              • Exhibit 152: NEURONETICS Inc. - Overview
              • Exhibit 153: NEURONETICS Inc. - Product / Service
              • Exhibit 154: NEURONETICS Inc. - Key offerings
            • 12.11 Nevro Corp.
              • Exhibit 155: Nevro Corp. - Overview
              • Exhibit 156: Nevro Corp. - Product / Service
              • Exhibit 157: Nevro Corp. - Key offerings
            • 12.12 OMRON Corp.
              • Exhibit 158: OMRON Corp. - Overview
              • Exhibit 159: OMRON Corp. - Business segments
              • Exhibit 160: OMRON Corp. - Key news
              • Exhibit 161: OMRON Corp. - Key offerings
              • Exhibit 162: OMRON Corp. - Segment focus
            • 12.13 PathMaker Neurosystems Inc.
              • Exhibit 163: PathMaker Neurosystems Inc. - Overview
              • Exhibit 164: PathMaker Neurosystems Inc. - Product / Service
              • Exhibit 165: PathMaker Neurosystems Inc. - Key offerings
            • 12.14 Saebo Inc
              • Exhibit 166: Saebo Inc - Overview
              • Exhibit 167: Saebo Inc - Product / Service
              • Exhibit 168: Saebo Inc - Key offerings
            • 12.15 Saluda Medical Pty Ltd.
              • Exhibit 169: Saluda Medical Pty Ltd. - Overview
              • Exhibit 170: Saluda Medical Pty Ltd. - Product / Service
              • Exhibit 171: Saluda Medical Pty Ltd. - Key offerings
            • 12.16 ShiraTronics
              • Exhibit 172: ShiraTronics - Overview
              • Exhibit 173: ShiraTronics - Product / Service
              • Exhibit 174: ShiraTronics - Key offerings
            • 12.17 Theranica Bio Electronics Ltd.
              • Exhibit 175: Theranica Bio Electronics Ltd. - Overview
              • Exhibit 176: Theranica Bio Electronics Ltd. - Product / Service
              • Exhibit 177: Theranica Bio Electronics Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 178: Inclusions checklist
                • Exhibit 179: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 180: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 181: Research methodology
                • Exhibit 182: Validation techniques employed for market sizing
                • Exhibit 183: Information sources
              • 13.5 List of abbreviations
                • Exhibit 184: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              spasticity treatment market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis